42
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Viramidine Demonstrates Better Safety Than Ribavirin in Monkeys But Not Rats

, M.Sc., , , &
Pages 191-211 | Published online: 29 Jul 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Keith R Kearney, James J Thornton & Victor J Navarro. (2008) Taribavirin for the treatment of chronic hepatitis C. Expert Opinion on Pharmacotherapy 9:18, pages 3243-3249.
Read now

Articles from other publishers (7)

Joshua Casaos, Sakibul Huq, Tarik Lott, Raphael Felder, John Choi, Noah Gorelick, Michael Peters, Yuanxuan Xia, Russell Maxwell, Tianna Zhao, Chenchen Ji, Thomas Simon, Julie Sesen, Sarah J. Scotland, Richard E. Kast, Jeffrey Rubens, Eric Raabe, Charles G. Eberhart, Eric M. Jackson, Henry Brem, Betty Tyler & Nicolas Skuli. (2018) Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors. Oncotarget 9:8, pages 8054-8067.
Crossref
F Volpin, J Casaos, J Sesen, A Mangraviti, J Choi, N Gorelick, J Frikeche, T Lott, R Felder, S J Scotland, T S K Eisinger-Mathason, H Brem, B Tyler & N Skuli. (2016) Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic. Oncogene 36:21, pages 3037-3047.
Crossref
Steven D. Dong, Chin-Chung Lin & Mel Schroeder. (2013) Synthesis and evaluation of a new phosphorylated ribavirin prodrug. Antiviral Research 99:1, pages 18-26.
Crossref
Christopher P Farrell, Giancarlo Mercogliano, Victor J Navarro & Simona Rossi. (2011) Taribavirin: potential future in the treatment of hepatitis C. Future Virology 6:2, pages 147-155.
Crossref
Mark S. Butler. (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Natural Product Reports 25:3, pages 475.
Crossref
Chin-chung Lin, Christine Xu, Nanqun Zhu & Li-Tain Yeh. (2006) Absorption, Metabolism, and Excretion of [14C]Viramidine in Humans. Antimicrobial Agents and Chemotherapy 50:7, pages 2368-2373.
Crossref
Mark S. Butler. (2005) Natural products to drugs: natural product derived compounds in clinical trials. Natural Product Reports 22:2, pages 162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.